- Pacira Pharmaceuticals (NASDAQ:PCRX +5%) Q2 results: Revenues: $84.1M (+18.6%); EXPAREL: $80.4M (+15.2%); Collaborative licensing and milestone revenue: $3M; Royalty revenue: $0.4M (-42.9%).
- Net Income: $2.6M; Non-GAAP Net Income: $9.9M; EPS: $0.06; Non-GAAP EPS: $0.24.
- 2018 Guidance: EXPAREL net product sales: $320M - 325M.
Pacira Pharma Q2 revenues up 19%
Recommended For You
More Trending News
About PCRX Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
PCRX | - | - |
Pacira BioSciences, Inc. |